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Abstract
In physics the concept of entanglement is well established and it has become increasingly apparent that all levels of biological organiza-
tion (communities, organisms, cells, metabolism) consist of mosaics of interactive networks. There is a universe of bioactive microbial
chemicals that have so far only been considered for their therapeutic applications; for example, the environmental roles of antibiotics
have been little investigated. At sub-inhibitory concentrations, so-called antibiotics have been shown to modulate bacterial functions in
subtle ways; they behave more like signals than toxins. It is proposed that networks of microbial cell signalling are primarily based on
the interactions of low molecular weight compounds with macromolecular receptors; studies of the nature of these signals will reveal
important information on the functions of microbial communities.
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Introduction
The title of this article is a translation of a credo of the
Haida people, an important Northwest Indian band who live
on the Queen Charlotte Islands off the coast of British
Columbia. It refers to the interdependent and interactive
relationship between people, animals, and their natural envi-
ronment, a concept that governs their lifestyle. The Haida
anticipated the theory of random networks in biology. A
more global concept of interdependence, the Gaia principle,
was later expounded by James Lovelock. I wish to discuss
the nature of the interconnectivity between and within
microbial cells, their hosts, and the environment, and the
fundamental role that bioactive small molecules play in the
kingdom of microbes.
What are antibiotics?
Organic chemists have long been interested in natural prod-
ucts, and their investigations have contributed to many
advances in chemistry, especially the total synthesis of com-
plex molecules with many chiral centres. Natural products
include an amazingly wide range of aliphatic, aromatic and
heterocyclic products of microbes and plants, all of which
are, by deﬁnition, bioactive molecules (although the bioactiv-
ity remains undetermined in most cases); many of these
compounds are vital in the treatment of human diseases to
this day. The discovery by Alexander Fleming and Selman
Waksman of bacterial and fungal small molecules with antimi-
crobial activity was the foundation of the modern pharma-
ceutical industry; the introduction of penicillin and
streptomycin completely transformed medicine and ushered
in the ‘golden age’ of antibiotics. For the ﬁrst time in human
history, infectious diseases could be cured. This is rightly
considered to be one of the ‘miracles’ of the 20th century.
Unfortunately, during this time, the study of therapeutic
functions dominated research, and scant attention was paid
to the natural roles of these bioactive small molecules.
In 1942, Waksman proposed the deﬁnition of an antibi-
otic: a microbial product that kills or inhibits the growth of
other microbes. However, it is now clear that this deﬁnition
applies to only one aspect of the biological activity of micro-
bial small molecules. They act in a concentration-dependent
manner to modulate a wide range of metabolic reactions in
environmental, clinical or laboratory situations. Waksman
revised his deﬁnition later, in part because of the realization
that the bacterial world is not one enormous battleﬁeld of
competing forces. It is now known that the number of differ-
ent types of organic compounds that make up the natural
small molecule world is enormous, quite possibly ten times
greater than the number of living species. They are part
of a biospheric interactome that links all cells and their
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components; small molecules add additional levels of
complexity to systems biology.
In recent times, with increasing knowledge of the diversity
and complexity of the microbial world, the possibility that
small organic molecules may play signiﬁcant roles in the
maintenance of microbial communities of terrestrial and mar-
ine environments has become relevant. Experimental
advances, especially in the identiﬁcation and study of tran-
scriptomes and proteomes, have revealed many unsuspected
molecular interactions in cells; cellular metabolism is not a
series of independent linear pathways but consists of a series
of hierarchical, connected networks [1]. One feature of
many of these interactions is the involvement of small mole-
cule signals and effectors.
Signalling and communities
In the bacterial kingdom, the concept of intercellular signal-
ling for the maintenance of multicellular communities and
regulation of their social behaviour is well known, as are the
phenomena of quorum sensing and the different roles of dif-
fusible molecules over concentration gradients [2]. The ubiq-
uity and chemical diversity of low molecular weight
compounds (<5000 Da) produced by most microbes is con-
sistent with this model.
Individual strains of large bacterial families such as the
Actinomycetes (the source of many antibiotics) have the
genetic capacity to synthesize more than 20 structurally dif-
ferent compounds [3]. Most of these compounds have not
been isolated or characterized; their existence is inferred
from the presence of speciﬁc biosynthetic gene clusters in
their host genomes. Those that have been isolated are usu-
ally identiﬁed functionally by their antibiotic activity in the
laboratory, with no consideration of their natural roles at
reduced concentrations. In fact, the evolution of natural
small molecules may be primarily associated with the sur-
vival of communities rather than the survival of the ﬁttest.
Their activities as therapies for a variety of human and ani-
mal diseases are consequences of their use in an entirely
different, artiﬁcial context.
Most bacterial communities are very complex and exist as
consortia of large numbers of different genera and subfami-
lies. One gram of soil contains upwards of 1000 different
bacterial strains; the human gastrointestinal tract (micro-
biome) is inhabited by some 1013 microbes with 1000 or
more phylotypes. The human oral cavity contains as many as
300 different types of bacteria [4,5]. Intercellular and intra-
cellular signalling is critical to the functioning of such commu-
nity structures during ﬂuctuating environmental and
nutritional states. It is probable that a collection of chemi-
cally diverse small molecules control these communities and
their interactions with their environments, such as epithelial
and buccal cells; the compounds act in a concentration-
dependent manner and rarely (if ever) attain severely static
or cidal concentrations. It has been suggested that the inter-
actions constitute a homeostatic process, but the nature and
complexity of the communities are as yet too ill-deﬁned to
permit this conclusion.
What are the receptors?
The notion of a world modulated by small molecules implies
that there must exist a large number of specialized receptors
responsible for many types of extant small molecule interac-
tions. One can envisage at least three different classes of
signalling processes (Fig. 1); there are probably more. The
best studied are those involving cellular receptors linked to
two-component regulatory systems, such as the well-studied
quorum sensing autoinducers that are found in many micro-
bial genera. Quorum sensing regulates a multitude of differ-
ent behaviours, including metabolism, motility and swarming,
virulence, luminescence, development, antibiotic production,
and horizontal gene transfer. The chemistry of the auto-
inducers encompasses many diverse structural types, and
over 100 different molecules have been identiﬁed. In addi-
tion, multiple autoinducers made by the same bacterium can
participate in cross-activation with different receptors; small
molecule antagonists of autoinducer activity have also been
identiﬁed [2]. Among their many functions, some autoin-
ducers have antimicrobial activity, e.g. the quinolones made
by pseudomonads [6].
The antibiotics, another large class of bacterial small mole-
cules, have a similar wide range of activities but operate
by different mechanisms. The natural products used as
Fig. 1. There are (at least) three types of interbacterial signalling.
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antibiotics act by binding to speciﬁc receptors that are
embedded in the cell macromolecules involved in replication,
transcription, translation or cell envelope formation. Each of
these complex structures possesses many potential receptor
sites for bioactive small molecules. Different regulons may be
affected by different chemical classes. For example, the ribo-
some is a huge RNA–protein complex with numerous associ-
ated protein factors. Studies of small molecule binding to
ribosomes (in the context of antibiotic mode of action stud-
ies) have revealed dozens of structurally speciﬁc receptors
and ligand–receptor interactions, each of which can lead to
modulation of distinct aspects of the function of the macro-
molecule in the cell [7]. It is likely that many more receptors
exist within the ribosome structure; recent mutational analy-
ses indicate a number of potential receptor sites on the large
ribosomal subunit [8]. Evidence for discrete effects of these
interactions comes from transcription studies with subinhibi-
tory concentrations of different ligands, showing a range of
responses due to binding at subinhibitory concentrations to
different receptors within the structure [9]. Similarly, cell
wall synthesis regulons are inﬂuenced by a number of small
molecules [10]; for example, the regulation of enzyme activ-
ity in bacteria has long been identiﬁed as mediated by the
speciﬁc binding of bioactive small molecules to proteins,
DNA, or RNA (e.g. allosteric activators, repressors, and ri-
boswitches) [11].
Resistance/recalcitrance
Internal cellular modulation (control) of the binding of low
molecular weight ligands to macromolecular receptors can be
brought about by enzymic modiﬁcations of the ligands, recep-
tors, efﬂux, etc., which are common reactions in bacteria.
These processes affecting ligand–receptor interactions deﬁne
the resistome, as many of the chemical modiﬁcations have
been identiﬁed as putative resistance mechanisms [12] and,
when expressed independently in heterologous hosts, protect
pathogenic bacteria against the activities of antibiotics.
Various modulation reactions may be converted into resis-
tance mechanisms by horizontal gene transfer and overex-
pression in heterologous cytoplasms, e.g. the bacterial
pathogens. Potential resistance mechanisms are widespread
and have been revealed by gene knockout studies in environ-
mental strains, etc. [13]. The situation is probably much
more complex, as most single mutations in a gene result in
disruptions of network activity. For example, mutations to
antibiotic resistance in ribosomal protein genes are known
to cause signiﬁcant variations in cell metabolic phenotypes.
Completely silent mutations may be rare. The soil and other
resistomes do not reﬂect the array of functions found in the
clinic, although many are considered to have been recruited
and disseminated by horizontal gene transfer.
Plants—rhizosphere
Microbes are not the only living organisms that make bioac-
tive small molecules. The plant world is replete with such
compounds, representing many structural types and bio-
chemical activities [2,14]. As with the antibiotics, many are
considered to be defence or repellence mechanisms. This
may be only part of the story, as it has been shown that
plant compounds can inﬂuence bacterial signalling and, con-
versely, bacterial compounds have signiﬁcant transcription
effects in plants. Work in my laboratory using bacterial
reporter libraries has shown that a variety of plant-produced
chemicals cause transcription modulation, conﬁrming that
environments like the rhizosphere are complex, intercon-
nected, pro-eukaryote communities [15].
Conclusions
Small molecule signalling is an important ﬁeld of study, and
much work is needed to decipher the nature of the mes-
sages. It is likely that not all will be amenable to study in the
laboratory, and in some cases it may be difﬁcult to distin-
guish between speciﬁc signalling, broadcasting, and just plain
noise.
A better understanding of the small molecule biology of
different environments could be turned to advantage for the
discovery of novel small molecule ligands, receptors and
reactions useful in clinical (and industrial?) applications. For
example, the identiﬁcation and examination of foci of cell–
cell signaling in soils may permit the direct identiﬁcation of
the signal origins from induced responses in reporter strains
and provide microbial sources of novel classes of bioactive
small molecules. Such approaches may eliminate much of the
heuristic (hit-or-miss) aspect of natural product drug discov-
ery. Small molecules are critical components of biological
systems, and as has been proposed [16], it is time that they
be included as part of the ‘central dogma’ along with DNA,
RNA, and protein.
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